Journal of International Oncology››2015,Vol. 42››Issue (2): 147-149.doi:10.3760/cma.j.issn.1673-422X.2015.02.018

Previous ArticlesNext Articles

Clinicopathological characteristics, diagnosis and treatment of combined small cell lung cancer

Men Yu, Hui Zhouguang

  1. Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100021, China
  • Online:2015-02-08Published:2015-02-02
  • Contact:Hui Zhouguang E-mail:drhuizg@163.com

Abstract:Combined small cell lung cancer (CSCLC) is a special subtype of small cell lung cancer (SCLC), which has a low incidence and diagnostic rate. However, the incidence and diagnostic rate appear an increasing tendency recently. The clinical features of CSCLC are similar to the pure SCLC, while it has a relatively limited stage. The main treatment pattern of CSCLC is multimodality therapy, though the response to chemotherapy in CSCLC is relatively poor. Survival between patients with CSCLC versus SCLC is similar. KPS, stage, composite components, tumor location and diameter, surgery margin are prognostic factors. Radiotherapy can benefit for the patients with ⅢA/ⅢB disease, positive lymph nodes, or with more metastatic lymph nodes after surgery.

Key words:Diagnosis,Therapy,Prognosis,Lung neoplasms